Oral delivery of peptides: opportunities and issues for translation

被引:50
作者
Brayden, David J. [1 ,2 ]
Alonso, Maria-Jose [3 ]
机构
[1] Univ Coll Dublin, UCD Sch Vet Med, Dublin 4, Ireland
[2] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland
[3] Univ Santiago Compostela, CIMUS Res Inst, Dept Pharm & Pharmaceut Technol, Campus Vida, Santiago De Compostela 15706, Spain
关键词
oral peptide delivery; nanomedicines; nanocarriers; intestinal permeation enhancers; nanotoxicology; anti-diabetic peptides;
D O I
10.1016/j.addr.2016.10.005
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
引用
收藏
页码:193 / 195
页数:3
相关论文
共 19 条
[1]
Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials [J].
Aguirre, T. A. S. ;
Teijeiro-Osorio, D. ;
Rosa, M. ;
Coulter, I. S. ;
Alonso, M. J. ;
Brayden, D. J. .
ADVANCED DRUG DELIVERY REVIEWS, 2016, 106 :223-241
[2]
Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier [J].
Beloqui, Ana ;
des Rieux, Anne ;
Preat, Veronique .
ADVANCED DRUG DELIVERY REVIEWS, 2016, 106 :242-255
[3]
Chemically modified peptides and proteins - critical considerations for oral delivery [J].
Buckley, Stephen T. ;
Hubalek, Frantisek ;
Rahbek, Ulrik Lytt .
TISSUE BARRIERS, 2016, 4 (02)
[4]
In vitro toxicity assessment of oral nanocarriers [J].
Ciappellano, Silvia Gabriella ;
Tedesco, Erik ;
Venturini, Marco ;
Benetti, Federico .
ADVANCED DRUG DELIVERY REVIEWS, 2016, 106 :381-401
[5]
NEW APPROACH FOR ORAL-ADMINISTRATION OF INSULIN WITH POLYALKYLCYANOACRYLATE NANOCAPSULES AS DRUG CARRIER [J].
DAMGE, C ;
MICHEL, C ;
APRAHAMIAN, M ;
COUVREUR, P .
DIABETES, 1988, 37 (02) :246-251
[6]
Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure [J].
Fouche, Marianne ;
Schafer, Michael ;
Berghausen, Jorg ;
Desrayaud, Sandrine ;
Blatter, Markus ;
Piechon, Philippe ;
Dix, Ina ;
Martin Garcia, Aimar ;
Roth, Hans-Jorg .
CHEMMEDCHEM, 2016, 11 (10) :1048-1059
[7]
Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs [J].
Griffin, Brendan T. ;
Guo, Jianfeng ;
Presas, Elena ;
Donovan, Maria D. ;
Alonso, Maria J. ;
O'Driscoll, Caitriona M. .
ADVANCED DRUG DELIVERY REVIEWS, 2016, 106 :367-380
[8]
Laklcireddy H.R., 2016, ADV DRUG DELIV REV, V106, P196
[9]
Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues [J].
Lundquist, P. ;
Artursson, P. .
ADVANCED DRUG DELIVERY REVIEWS, 2016, 106 :256-276
[10]
Intestinal permeation enhancers for oral peptide delivery [J].
Maher, Sam ;
Mrsny, Randall J. ;
Brayden, David J. .
ADVANCED DRUG DELIVERY REVIEWS, 2016, 106 :277-319